Altimmune (ALT) Other Non-Current Assets (2010 - 2026)

Altimmune (ALT) has 17 years of Other Non-Current Assets data on file, last reported at $746000.0 in Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $746000.0, down 53.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $746000.0 (down 53.87% YoY), and the FY2025 annual result was $1.4 million, down 13.06% from the prior year.
• Other Non-Current Assets slipped to $746000.0 in Q1 2026 per ALT's latest filing, from $1.4 million in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $1.7 million in Q2 2024 and troughed at $299000.0 in Q1 2024.
• A 5-year average of $987823.5 and a median of $747000.0 in 2022 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2022 and 2026: Other Non-Current Assets surged 603.38% in 2022, then tumbled 53.87% in 2026.
• A 5-year view of Other Non-Current Assets shows it stood at $615000.0 in 2022, then sank by 40.98% to $363000.0 in 2023, then soared by 351.52% to $1.6 million in 2024, then decreased by 13.06% to $1.4 million in 2025, then slumped by 47.65% to $746000.0 in 2026.
• Business Quant data shows ALT's Other Non-Current Assets at $746000.0 in Q1 2026, $1.4 million in Q4 2025, and $1.5 million in Q3 2025.